medigraphic.com
ISSN 2078-7162 (Print)

2014, Number 1

<< Back Next >>

Rev Cub de Med Fis y Rehab 2014; 6 (1)

Treatment of patient with abdominal obesity as prevention or progression of the metabolic syndrome

Pérez FL, Pérez RZM, Mora GSR, Guerrero DL

Language: Spanish
References: 36
Page: 2-15
PDF size: 116.75 Kb.


ABSTRACT

Objective: To determine the utility of the treatment with average Kotz and the magnetic bed in the decrease of the fat in patient with abdominal obesity.
Method: He/she was carried out a prospective quasi experimental study in 60 patients with abdominal obesity and hiperlipidemia coming from the consultation of internal medicine of the University Hospital "Dr. Carlos J Finlay" from July 2011-July 2012. Before and after the treatment they were carried out complete physical exam, the abdominal circumference was measured. He/she was also carried out cholesterol and triglycerides. All the patients only received treatment with magnetic and average bed Kotz in abdomen during 15 min each one, for a total of 30 sessions. The prosecution of the results was carried out with the student test, the non parametric test of Wilcoxon (you give birth to even of Wilcoxon) with an error type 1 (p ‹ 0,05), for the hypothesis tests it was used intervals of trust to 95 % (IC 95 %).
Results: The most frequent thing found in the sample was bigger than 40 years of the feminine sex and the white race and the pathological antecedent the arterial hypertension. After the treatment the patients diminished the corporal weight in 5,215 kg, the abdominal circumference in 10 cm or more, the IMC in 2, 0333 kg/ m2. The cholesterol diminished in 1.46083 mmol/L and the triglycerides in 1,01017 mmol/L 100 % of the patients presented good arterial tensions, that which was highly significant in the statistical analysis.
Conclusions: The magnetic field and the average Kotz were effective in the treatment of most patients with abdominal obesity, when diminishing the abdominal circumference, to take to good figures the arterial tension and to diminish the IMC, as well as the figures of cholesterol and triglycerides at the end of 30 treatment sessions.


REFERENCES

  1. Miguel Soca PE; Aluett Niño PeñaII. Consecuencias de la obesidad. ACIMED. 2009; 20(4): 84-92.

  2. Redinger RN. The prevalence and etiology of nongenetic obesity and associated disorders. South Med J. 2008; 101(4):395-9.

  3. Quirantes Moreno AJ; López Ramírez M; Hernández Meléndez E; Pérez Sánchez A. Estilo de vida, desarrollo científico-técnico y obesidad. Rev Cubana Salud Pública. 2009; 35(3).

  4. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003; 289:187-93

  5. Hernández I. Obesidad y salud pública. Endocrinol Nutr. 2004; 51(2):35-65.

  6. Roca Goderich R. Temas de Medicina Interna. Cap. 36 Obesidad T. 2. La Habana: Editorial Ciencias Médicas; 2002. Pp. 284-8(2).

  7. Álvarez Síntes R. Medicina General Integral. Principales afecciones en el contexto familiar y social. Cap. 74. V. 2. Afecciones por exceso y por defecto. Obesidad. La Habana: Editorial Ciencias Médicas; 2008. pp. 315-22.

  8. El Manual Merk. Undécima edición. Cap. 1. España: Editorial Elsevier; 2007. pp. 59-65.

  9. Los efectos de los campos magnéticos en los seres vivos. Biomagnetismo y Magnetoterapia, 2006 [Internet]. Disponible en: http://www.imagines.emplenitud.com .

  10. Martín Cordero J E, García Delgado J A. Efectos y aplicaciones de la magnetoterapia. [Internet] 2006. Disponible en: http://www.biocyber.com.mx/

  11. Martín Cordero J. Agentes físicos terapéuticos. Cap. 23. Electroterapia de media frecuencia. La Habana: Editorial Ciencias Médicas; 2008. pp. 305.

  12. Sartorio A, Maffiuletti NA, Agosti F, Lafortuna CL. Gender-related changes in body composition, muscle strength and power output after a short-term multidisciplinary weight loss intervention in morbid obesity. J Endocrinol Invest. 2005; 28(6):494-501.

  13. Bonet M, Jiménez S, Díaz O, García R, Cañizares M, Barroso. Encuesta Nacional de Factores de Riesgo y Enfermedades Crónicas. Instituto Nacional de Higiene y Epidemiología. Instituto de Nutrición e Higiene de los Alimentos. Resultados preliminares. La Habana, Cuba, 2001.

  14. Haffner SM. El síndrome metabólico, inflamación, enfermedad cardiovascular y diabetes mellitus. Am J Cardiol. 2006; 97:3-11.

  15. Miguel Soca PE. El síndrome metabólico: un alto riesgo para individuos sedentarios. Acimed. 2009; 20(2).

  16. Bustillo Solano E; Pérez Francisco Y; Brito García A; González Iglesia A; Castañeda Montano D; Santos González M; Bustillo Madrigal E. Síndrome metabólico: Un problema de salud no diagnosticado. Rev Cubana Endocrinol. 2011; 22(3):167-81.

  17. Schusdziarra V, Hausmann M, Erdmann J. Patient selection for surgical treatment of obesity. Rozhl Chir. 2006; 85(9):436-40.

  18. González Sotolongo O, Arpa Gámez A. Rev Cubana Med Mil. 40(3-4) jul - dic 2011.

  19. Tarkhan-Mouravi ID, Purtseladze NA. Influence of treatment with variable magnetic field of low frequency in low mountain environment on cardiohemodynamic index of patients with arterial hypertension Georgian Med News. 2006 Jun ;( 135):109-13.

  20. Minenkov AA, Orekhova EM, Zubkova SM, Lebedeva EV, Varakina NI, Luk'ianova TV, Chuich NG, Donova IA, Alimova VN. Magnetotherapy of hypertensive patients Vopr Kurortol Fizioter Lech Fiz Kult. 2005 May-Jun ;(3):53-4.

  21. Bansal H.L. Magnetoterapia. Argentina: Ediciones Contingente; 1993. Pp.64-5.

  22. Madroñero de la Cal A. Utilización terapéutica de los campos magnéticos. Fundamentos del biomagnetismo. Patología del aparato locomotor. 2004; 2 (1): 22-37 72

  23. Rosen AD. Mechanism of action of moderate-intensity static magnetic fields on biological systems. Cell Biochem Biophys. 2003; 39:163-73.

  24. Baureus Koch CL, Sommarin M, Persson BR, Salford LG, Eberhardt JL. Interaction between weak low frequency magnetic fields and cell membranes. Bioelectromagnetics. 2003 Sep; 24(6):395-402.

  25. Ohata R, Tomita N, Ikada Y. Effect of a static magnetic field on ion transport in a cellulose membrane. J Colloid Interface Sci. 2004; 270:413-6.

  26. Fernández Brito JE. Centro de investigaciones y referencias de ateroesclerosis de La Habana. Universidad de La Habana. Cuba.1998.

  27. Canöz M, Erdenen F, Uzun H, Müderrisglu C, Aydin S. The relationship of inflammatory cytokines with asthma and obesity. Clin Invest Med. 2008; 31(6):373-379.

  28. Markoff B, Amsterdam A. Impact of obesity on hospitalized patients. Mt Sinai J Med. 2008; 75:45-9.

  29. Bordiushkov IN, et al. Structural-funcional changes in lymphocyte and erythrocyte membranes after exposure to alterning manetic field.Vopr Med Khim 2000 Jan-Feb; 469:10; 72-80.

  30. Dolgikh VV, Bimbaev AB, Bairova TA, Duibanova NV.Impulse low-intensity electromagnetic field in the treatment of adolescents with essential arterial hypertension. Vopr Kurortol Fizioter Lech Fiz Kult. 2005 Nov-Dec ;( 6):13-5.

  31. Dasdag S, Sert C, Akdag Z, Batun S. Effects of extremely low frequency electromagnetic fields on hematologic and immunologic parameters in welders. Arch Med Res. 2002 Jan-Feb; 33(1):29-32.

  32. Quesada Vargas O. Rev. Actualización Médica Periódica (88): 1-24. 2008.

  33. Martín Cordero J E, García Delgado J A. Efectos y aplicaciones de la magnetoterapia. [Internet]. 2006. Disponible en: http://bvs.sld.cu

  34. Okano H, Ohkubo C. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats. Bioelectromagnetics. 2005 Dec; 26(8):611-23.

  35. Okano H, Ohkubo C. Effects of neck exposure to 5.5 mT static magnetic field on pharmacologically modulated blood pressure in conscious rabbits. Bioelectromagnetics. 2005 Sep; 26(6):469-80.

  36. Dolgikh VV, Bimbaev AB, Bairova TA, Duibanova NV.Impulse low-intensity electromagnetic field in the treatment of adolescents with essential arterial hypertension. Vopr Kurortol Fizioter Lech Fiz Kult. 2005 Nov-Dec (6):13-5.




2020     |     www.medigraphic.com